CN Stock MarketDetailed Quotes

301130 Jilin Province Xidian Pharmaceutical Sci-Tech Development

Watchlist
  • 26.76
  • +1.58+6.27%
Trading Aug 15 13:27 CST
2.16BMarket Cap39.35P/E (TTM)

About Jilin Province Xidian Pharmaceutical Sci-Tech Development Company

The company is a technology-based pharmaceutical enterprise focusing on R&D, production and sales of chemical raw materials and formulations. It is one of the first pharmaceutical companies in Jilin Province to pass the “High-tech Enterprise” certification in 2008. It has also been successively rated as a “National High-tech Enterprise” and a “National Torch Program Key High-tech Enterprise”. After more than 30 years of differentiated development, the company has formed a product system with anti-anemia drugs, drugs for treating mental disorders, and raw materials as the core, and auxiliary drugs for cardiovascular diseases and drugs for anti-tumor treatment. The company is mainly engaged in R&D, production and sales of chemical raw materials and formulations. The company's products focus on anti-anemia drugs, drugs for circulatory disorders, drugs for mental disorders, and the production of raw materials.

Company Profile

Short Name-A西点药业
Symbol-A301130
Company NameJilin Province Xidian Pharmaceutical SciTech Development Co.,Ltd
Listing DateFeb 23, 2022
Issue Price22.55
Shares Offered20.20M share(s)
FoundedMar 21, 1990
Legal Representativejun zhang
General Managerjun zhang
Secretaryyinji zhang
Accounting FirmDahua Certified Public Accountants (Special General Partnership)
Securities Representativeshengyu zheng
Legal CounselBeijing Hairun Tianrui Law Firm
Employees269
Phone0431-80606619
Office AddressNo. 1471, Satellite Road, Economic Development Zone, Changchun City, Jilin Province
Zip Code130000
Registered AddressNo. 777 West Point Street, Panshi Economic Development Zone, Jilin City, Jilin Province
Fax0432-65888287
Emailxidianyy@xidianyy.com
Business License220000000033702
BusinessBusiness management; production of tablets, hard capsules, sterile raw materials (sodium ferulate), APIs (escitalopram oxalate, ferrous sulfate, ferrous fumarate, glycerol, calcium carbonate, zinc oxide, zinc oxide, zinc sulfate, potassium chloride, heavy magnesium carbonate, copper sulfate, zolephosphate, and rivexin), freeze-dried powder injections. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • jun zhang
  • Chairman, Directors, General Manager, Chairman of the Strategy Committee
  • 700.00K
  • shumin liu
  • Directors
  • 62.50K
  • yonghong meng
  • Directors, Deputy General Manager, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 300.00K
  • zhifeng wang
  • Directors, Audit Committee Members
  • --
  • taigen shen
  • Directors
  • --
  • yingxiu shi
  • Directors, Deputy General Manager, Nomination Committee Members
  • 300.00K
  • xiangjun lu
  • Independent Directors, Nomination Committee Members, Chairman of the Audit Committee
  • 33.30K
  • nannan wu
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 33.30K
  • bing su
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee, Member of the Strategy Committee
  • 80.00K
  • yinji zhang
  • Board Secretary, Deputy General Manager
  • --
  • shengyu zheng
  • Securities Affairs Representative
  • --
  • yulin hou
  • Chairman of the Supervisory Board, Employee Supervisors
  • 60.00K
  • jin cheng
  • Auditors
  • 113.40K
  • xianping pan
  • Auditors
  • --
  • duanxiang ma
  • Auditors
  • --
  • si meng
  • Chief Financial Officer
  • 125.00K
  • libo wang
  • Employee Supervisors
  • 150.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg